Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment

Vaccine

Volumn 28, Issue 10, 2010, Pages 2201-2206

  Segat, Ludovica ^a,b   Brandão, Lucas A C ^a   Guimarães, Rafael L ^a   Pontillo, Alessandra ^b   Athanasakis, Emmanouil ^b   de Oliveira, Rafael Martins ^c   Arraes, Luiz C ^d   de Lima Filho, Josè Luiz ^a   Crovella, Sergio ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Dendritic cell immunotherapy; HIV infection; Innate immunity

Indexed keywords

DENDRITIC CELL VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DNA POLYMORPHISM; ETHNIC GROUP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOTHERAPY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77049123430     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.056     Document Type: Article

References (19)

1. Lu W., Arraes L.C., Ferreira W.T., and Andrieu J.M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med 10 December (12) (2004) 1359-1365
2. Andrieu J.M., and Lu W. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results. J Intern Med 261 February (2) (2007) 123-131
3. Rinaldo C.R. Dendritic cell-based human immunodeficiency virus vaccine. J Intern Med 265 January (1) (2009) 138-158
4. Alves-Silva J., da Silva Santos M., Guimarães P.E., Ferreira A.C., Bandelt H.J., Pena S.D., et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 67 (2000) 444-461
5. Excoffier L., Laval G., and Schneider S. Arlequin ver 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 1 (2005) 47-50
6. Boldt A.B., Culpi L., Tsuneto L.T., de Souza I.R., Kun J.F., and Petzl-Erler M.L. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol 67 September (9) (2006) 722-734
7. Bukrinsky M.I., Nottet H.S., Schmidtmayerova H., Dubrovsky L., Flanagan C.R., Mullins M.E., et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 181 February (2) (1995) 735-745
8. Sherry B., Schmidtmayerova H., Zybarth G., Dubrovsky L., Raabe T., and Bukrinsky M. Nitric oxide regulates MIP-1alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response. Mol Med 6 June (6) (2000) 542-549
9. González-Nicolás J., Resino S., Jiménez J.L., Alvarez S., Fresno M., and Muñoz-Fernández M.A. Tumor necrosis factor-alpha and nitric oxide in vertically HIV-1-infected children: implications for pathogenesis. Eur Cytokine Netw. 12 July-September (3) (2001) 437-444
10. García M., del Llano A.M., Cruz-Colón E., Saavedra S., and Lavergne J.A. Characteristics of nitric oxide-induced apoptosis and its target cells in mitogen-stimulated peripheral blood mononuclear cells from HIV+ subjects. Immunol Invest 30 4 (2001 Nov) 267-287
11. Fernández-Ruiz V., González A., and López-Moratalla N. Effect of nitric oxide in the differentiation of human monocytes to dendritic cells. Immunol Lett 93 April (1) (2004) 87-95
12. Duan J., Avci F.Y., and Kasper D.L. Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci USA 105 April (13) (2008) 5183-5188
13. Heggelund L., Mollnes T.E., Ueland T., Christophersen B., Aukrust P., and Frøland S.S. Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr 32 April (4) (2003) 354-361
14. Heggelund L., Mollnes T.E., Espevik T., Müller F., Kristiansen K.I., Aukrust P., et al. Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection. Eur J Clin Invest 35 December (12) (2005) 765-770
15. Piras I.S., Falchi A., Melis A., De Cian M.C., Calò C.M., Vona G., et al. High frequencies of short alleles of NOS1 (CA)n polymorphism in beta(0)39 carriers from Corsica Island (France). Exp Mol Pathol 86 April (2) (2009) 136-137
16. Turner M.W. Mannose-binding lectin (MBL) in health and disease. Immunobiology 199 August (2) (1998) 327-339
17. Catano G., Agan B.K., Kulkarni H., Telles V., Marconi V.C., Dolan M.J., et al. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J Infect Dis 198 July (1) (2008) 72-80
18. Bernig T., Breunis W., Brouwer N., Hutchinson A., Welch R., Roos D., et al. An analysis of genetic variation across the MBL2 locus in Dutch caucasians indicates that 3′ haplotypes could modify circulating levels of MBL. Hum Genet 118 (2005) 404-415
19. MacDonald S.L., Downing I., Turner M., and Kilpatrick D.C. Is mannan-binding lectin (MBL) detectable on monocytes and monocyte-derived immature dendritic cells?. Biochem Soc Trans 36 December (Pt 6) (2008) 1497-1500